Estrella Immunopharma
Estrella Biopharma is a biotech firm that is dedicated to advancing cancer treatment with CD19-Redirected ARTEMIS T Cells, aiming to enhance patient outcomes. Leveraging recent breakthroughs in cell therapy, the company focuses on developing transformative medicines not only for hematological malignancies but also for solid tumors. Estrella Biopharma stands at the forefront of pioneering next-generation T-cell therapies, addressing treatment challenges across a spectrum of cancers.
Domain
estrellabio.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$8.0M
Founded
2021
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Estrella Immunopharma use?+
Estrella Immunopharma uses 12 technologies including Sentry, Wix, GSAP.
What industry is Estrella Immunopharma in?+
Estrella Immunopharma operates in the Biotechnology industry.
Where is Estrella Immunopharma based?+
Estrella Immunopharma is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026